Back to mobile site
Get it on Google Play

Silence Therapeutics to discuss Phase 2 divesiran trial results

August 9, 2026 5:00 PM EDT Send to a Friend
Silence Therapeutics plc (Nasdaq: SLN) announced it will host a conference call and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login